Should patients with Ph-negative acute lymphoblastic leukaemia who reach minimal residual disease negativity have HSCT?
Authors: Nicolas Boissel
Published: 2023-12-20
DOI:
10.1016/s2352-3026(23)00364-2
Source:
Full article
Abstract
No abstract found.